Standout Papers

Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Grow... 2008 2026 2014 2020 508
  1. Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations (2008)
    Seiji Yano, Wei Wang et al. Cancer Research

Immediate Impact

2 by Nobel laureates 35 from Science/Nature 74 standout
Sub-graph 1 of 23

Citing Papers

Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
Natural killer cell therapies
2024 StandoutNature
4 intermediate papers

Works of Soji Kakiuchi being referenced

HM1.24 (CD317) is a novel target against lung cancer for immunotherapy using anti-HM1.24 antibody
2008
Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations
2008 Standout

Author Peers

Author Last Decade Papers Cites
Soji Kakiuchi 899 842 989 41 1.9k
Dana T. Aftab 567 869 794 45 1.8k
Lynne D. Berry 1048 915 779 33 1.8k
Haruhiro Yukiue 1046 811 829 71 2.0k
Cheng‐long Huang 658 966 1289 66 2.3k
Rachel Tsan 658 1320 1334 29 2.5k
Amrita Desai 1088 1292 649 35 2.3k
Monica Motwani 555 1107 871 45 1.9k
Rosa Caputo 900 1345 1042 21 2.2k
Harold Keer 1181 615 1274 74 2.5k
Jean–Louis Fischel 598 1205 802 62 1.9k

All Works

Loading papers...

Rankless by CCL
2026